UHRF1 and leukemia: We found that UF146 significantly delayed the leukemia development in the Uhrf1fl/fl group but not in the Uhrf1Δ/Δ group (Supplementary information, Fig. S9c, d), indicating that UF146 specifically targets Uhrf1 in vivo.